Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New insights into the second generation antihistamines.

G M Walsh1, L Annunziato, N Frossard

  • 1Department of Medicine and Therapeutics, University of Aberdeen Medical School, Scotland. g.m.walsh@abdn.ac.uk

Drugs
|March 29, 2001
PubMed
Summary

Second generation antihistamines vary significantly in safety and efficacy, despite appearing similar. Careful consideration of individual drug profiles is crucial for optimal allergy treatment and to avoid potential adverse effects like cardiotoxicity and somnolence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Olanzapine as an add-on, pre-operative anti-emetic drug for postoperative nausea or vomiting: a randomised controlled trial.

Anaesthesia·2023
Same author

Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.

Journal for immunotherapy of cancer·2023
Same author

Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study.

Infectious diseases and therapy·2022
Same author

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.

Scientific reports·2022
Same author

Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.

The Journal of antimicrobial chemotherapy·2021
Same author

Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain.

The Lancet regional health. Europe·2021

Area of Science:

  • Pharmacology
  • Allergy and Immunology
  • Drug Safety

Background:

  • Second-generation antihistamines are widely used for allergy treatment.
  • They are generally considered safe and effective, with a favorable therapeutic index.
  • However, their classification as a homogeneous group may be misleading.

Purpose of the Study:

  • To highlight the heterogeneity among second-generation antihistamines.
  • To discuss the varying safety profiles, including cardiotoxicity and drug interactions.
  • To explore potential anti-inflammatory effects and adjunct use in asthma therapy.

Main Methods:

  • Review of existing literature on second-generation antihistamines.
  • Comparative analysis of chemical structures, pharmacokinetics, and pharmacodynamics.

Related Experiment Videos

  • Evaluation of reported adverse effects and clinical trial data.

    • Main Results:

    • Significant differences exist in chemical structure, metabolism, and tissue distribution.
    • Some agents possess cardiotoxic potential or risk of drug interactions.
    • Variability in anti-inflammatory properties and potential for somnolence is observed.

    Conclusions:

    • The current broad classification of second-generation antihistamines obscures important differences.
    • A more refined classification, potentially leading to a 'third generation,' is needed.
    • Future antihistamine development should prioritize low toxicity, minimal drug interactions, and lack of sedation.